道明光學(002632.SZ):目前公司石墨烯膜應用於努比亞紅魔8S Pro等
格隆匯1月5日丨道明光學(002632.SZ)在投資者互動平台表示,目前公司石墨烯膜應用於努比亞紅魔8S Pro、8/8pro/8pro+、紅魔9Pro、Z50型號手機,OPPO Find N3 Flip摺疊屏手機;及HW品牌手錶watch4 系列、Robo & Kala、聯想等品牌產品;公司2024年將繼續深耕反光材料行業的同時,持續推動公司新材料行業市場拓展。同時,公司將以杭州研究院為平台,圍繞超精密加工做產業延伸;公司會在定期報吿中披露每季度末的股東户數,敬請關注公司定期報吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.